Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:03 PM
Ignite Modification Date:
2025-12-24 @ 10:03 PM
NCT ID:
NCT07126535
Eligibility Criteria:
Inclusion Criteria:
* Male or female ≥ 18 years of age
* Confirmed histologic diagnosis of BE with dysplasia or intramucosal carcinoma (IMCa)
* Ability to take high-dose proton pump inhibitor (PPI) therapy (such as omeprazole 40 mg BID)
* Willing to undergo multiple rounds of endoscopic eradication therapy (EET) for management of BE (which is the guideline clinical recommendation for management of this disease)
Exclusion Criteria:
* History of esophageal ablation
* History of esophageal stricture
* History of esophageal or gastric surgery
* Pregnancy
* History of achalasia
* History of delayed gastric emptying confirmed by 4-hour gastric emptying study
* Receipt of glucagon-like peptide-1 agonists
* Adults lacking the capacity to consent for self
* Lack of English fluency
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07126535
Study Brief:
Protocol Section:
NCT07126535